Cargando…

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer

IMPORTANCE: If magnetic resonance imaging (MRI) mitigates overdiagnosis of prostate cancer while improving the detection of clinically significant cases, including MRI in a screening program for prostate cancer could be considered. OBJECTIVE: To evaluate the benefit-harm profiles and cost-effectiven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callender, Thomas, Emberton, Mark, Morris, Stephen, Pharoah, Paul D. P., Pashayan, Nora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953309/ https://www.ncbi.nlm.nih.gov/pubmed/33704474 http://dx.doi.org/10.1001/jamanetworkopen.2020.37657

Ejemplares similares

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
por: Pashayan, Nora, et al.
Publicado: (2018)

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
por: Callender, Tom, et al.
Publicado: (2019)

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging
por: Robinson, David, et al.
Publicado: (2023)

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study
por: Hao, Shuang, et al.
Publicado: (2022)

Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer
por: Heijnsdijk, Eveline A M, et al.
Publicado: (2020)

Magnetic Resonance Imaging–Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
por: Jayadevan, Rajiv, et al.
Publicado: (2019)

The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023)

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015)

Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis
por: Elwenspoek, Martha M. C., et al.
Publicado: (2019)

Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?
por: Chowdhury, Susmita, et al.
Publicado: (2015)

Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study
por: Boesen, Lars, et al.
Publicado: (2018)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues
por: Hall, A.E., et al.
Publicado: (2014)

The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs
por: van der Poort, Esmée K. J., et al.
Publicado: (2022)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

Cost effectiveness of the NHS breast screening programme: life table model
por: Pharoah, Paul D P, et al.
Publicado: (2013)

Do cancer risk and benefit–harm ratios influence women’s consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries
por: Rebitschek, Felix G., et al.
Publicado: (2019)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

Parent-Perceived Benefits and Harms Associated With Internet Use by Adolescent Offspring
por: Kimball, Harry Graff, et al.
Publicado: (2023)

Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population
por: Rochester, Mark A, et al.
Publicado: (2009)

Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications
por: Altay, Mehmet Sefa, et al.
Publicado: (2022)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance
por: Salguero, Joseba, et al.
Publicado: (2021)

Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy
por: Park, Jung Jae, et al.
Publicado: (2022)

Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)
por: Faria, Rita, et al.
Publicado: (2018)

Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test
por: Abashidze, Nino, et al.
Publicado: (2021)

Contemporary benefit‐harm profile over two decades in primary prophylactic ICD‐therapy
por: Kleemann, Thomas, et al.
Publicado: (2019)

Magnetic Resonance Imaging-Guided Prostate Biopsy: Present and Future
por: Kim, Chan Kyo
Publicado: (2015)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

AB190. Could magnetic resonance imaging help identify the presence of prostate cancer before initial biopsy? The development of nomogram predicting the outcomes of prostate biopsy in the Chinese population
por: Fang, Dong, et al.
Publicado: (2016)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy
por: Pereira, Nalisson Marques, et al.
Publicado: (2023)

There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022)

Accuracy of Magnetic Resonance Imaging–Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial
por: Sutton, Elizabeth J., et al.
Publicado: (2021)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
por: Porpiglia, Francesco, et al.
Publicado: (2015)

Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy
por: Truong, Matthew, et al.
Publicado: (2017)

Diagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy
por: Zhou, Yi, et al.
Publicado: (2018)

Targeted prostate biopsy using magnetic resonance imaging-ultrasound fusion
por: Bockholt, Nathan, et al.
Publicado: (2015)

The urologist’s learning curve of “in-bore” magnetic resonance-guided prostate biopsy
por: Rosenzweig, Barak, et al.
Publicado: (2021)

Magnetic resonance imaging-guided prostate biopsy—A review of literature
por: Seetharam Bhat, Kulthe Ramesh, et al.
Publicado: (2021)

Transperineal Prostate Biopsy Targeted by Magnetic Resonance Imaging Cognitive Fusion
por: Drăgoescu, Petru Octavian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_llljtn4sqra784v1k1o9peut5o